Sign up to save your podcasts
Or
Share BioAge is translating insights from the science of aging into new medicines
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
BioAge is translating insights from the science of aging into new medicines
Scott Neidhold, Director in RBC’s Life Sciences Investment Banking Practice, sits down with Kristen Fortney, CEO and Co-Founder of BioAge, for a deep dive into how her company is turning cutting-edge aging science into real therapeutic breakthroughs — and what it means for the future of biopharma.
View all episodes
By RBC Capital Markets
5
1212 ratings
Scott Neidhold, Director in RBC’s Life Sciences Investment Banking Practice, sits down with Kristen Fortney, CEO and Co-Founder of BioAge, for a deep dive into how her company is turning cutting-edge aging science into real therapeutic breakthroughs — and what it means for the future of biopharma.
More shows like Pathfinders in Biopharma
View all
The Bill Simmons Podcast
30,050 Listeners
RBC's Markets in Motion
39 Listeners
Industries in Motion
10 Listeners
Powering Sustainable Ideas
0 Listeners
The Rest Is Politics
3,081 Listeners
Macro Minutes
3 Listeners
Strategic Alternatives
17 Listeners
The Rest Is Politics: US
2,275 Listeners